Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2019-03-06 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NANTES (44200), Loire-Atlantique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE SAINT JACQUES : revenue, balance sheet and financial ratios
PHARMACIE SAINT JACQUES is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NANTES (44200),
this company of category PME
shows in 2023 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SAINT JACQUES (SIREN 849199765)
Indicator
2025
2024
2023
2022
2021
2020
Revenue
N/C
N/C
1 804 213 €
N/C
N/C
N/C
Net income
35 227 €
61 192 €
122 168 €
130 981 €
104 609 €
47 885 €
EBITDA
N/C
N/C
138 957 €
N/C
N/C
N/C
Net margin
N/C
N/C
6.8%
N/C
N/C
N/C
Revenue and income statement
Im Jahr 2025 erzielt PHARMACIE SAINT JACQUES ein positives Nettoergebnis von 35 k€. Entwicklung 2020-2025: 48 k€ -> 35 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
35 227 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 100%. Der Verschuldungsgrad ist hoch: Der Verhandlungsspielraum mit Banken ist reduziert. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 42%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
99.525%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.941%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE SAINT JACQUES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Debt ratio
1258.397
494.363
259.977
165.853
125.7
99.525
Financial autonomy
6.212
14.659
23.664
33.706
37.852
41.941
Repayment capacity
None
None
None
5.613
None
None
Cash flow / Revenue
None%
None%
None%
7.034%
None%
None%
Sector positioning
Verschuldungsgrad
99.532025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-8 pts over 3 years
Im Jahr 2025 liegt über dem Median der Branche das verschuldungsgrad von PHARMACIE SAINT JACQUES (99.53). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Eine Reduzierung könnte die finanzielle Stärke verbessern.
Finanzielle Autonomie
41.94%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average
Im Jahr 2025 liegt unter dem Median der Branche das finanzielle autonomie von PHARMACIE SAINT JACQUES (41.9%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Eine Verbesserung würde die Wettbewerbsposition stärken.
Rückzahlungsfähigkeit
5.61 ans2023
2023
Q1: 0.95 ans
Med: 3.58 ans
Q3: 7.48 ans
Average
Im Jahr 2023 liegt über dem Median der Branche das rückzahlungsfähigkeit von PHARMACIE SAINT JACQUES (5.6 ans). Dieses Verhältnis gibt die Anzahl der Jahre an, die zur Rückzahlung der Schulden mit dem Cashflow benötigt werden. Eine Reduzierung könnte die finanzielle Stärke verbessern.
Liquidity ratios
Die Liquiditätsquote beträgt 154.74. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
154.744
Liquidity indicators evolution PHARMACIE SAINT JACQUES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
2024
2025
Liquidity ratio
140.112
189.267
199.591
266.969
193.538
154.744
Interest coverage
None
None
None
3.412
None
None
Sector positioning
Liquiditätsquote
154.742025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average-37 pts over 3 years
Im Jahr 2025 liegt unter dem Median der Branche das liquiditätsquote von PHARMACIE SAINT JACQUES (154.74). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Eine Verbesserung würde die Wettbewerbsposition stärken.
Zinsdeckung
3.41x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Gut
Im Jahr 2023 liegt über dem Median der Branche das zinsdeckung von PHARMACIE SAINT JACQUES (3.4x). Dieses Verhältnis gibt an, wie oft das Betriebsergebnis die Zinsaufwendungen deckt. Diese komfortable Position bietet eine nennenswerte Sicherheitsmarge.
Working capital requirement (WCR) and payment terms
Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE SAINT JACQUES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
134 125 €
0 €
0 €
Inventory turnover (days)
0
0
0
21
0
0
Customer payment term (days)
169
162
167
4
0
0
Supplier payment term (days)
790
752
937
27
0
0
Positioning of PHARMACIE SAINT JACQUES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE SAINT JACQUES is estimated at
559 585 €
(range 379 737€ - 878 066€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
379k€559k€878k€
559 585 €Range: 379 737€ - 878 066€
NAF 5 année 2025
Valuation method used
Net Income Multiple
35 227 €
×
15.9x
=559 585 €
Range: 379 737€ - 878 066€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SAINT JACQUES with other companies in the same sector:
Frequently asked questions about PHARMACIE SAINT JACQUES
What is the revenue of PHARMACIE SAINT JACQUES ?
The revenue of PHARMACIE SAINT JACQUES in 2023 is 1.8 M€.
Is PHARMACIE SAINT JACQUES profitable?
Yes, PHARMACIE SAINT JACQUES generated a net profit of 35 k€ in 2025.
Where is the headquarters of PHARMACIE SAINT JACQUES ?
The headquarters of PHARMACIE SAINT JACQUES is located in NANTES (44200), in the department Loire-Atlantique.
Where to find the tax return of PHARMACIE SAINT JACQUES ?
The tax return of PHARMACIE SAINT JACQUES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SAINT JACQUES operate?
PHARMACIE SAINT JACQUES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart